XENEXenon Pharmaceuticals Inc.
What is the market doing?
No clear lean: insiders net buying, but in a downtrend (−32% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −32% vs its 200-day average.
Insiders were net buyers over the 90 days ending Oct 22, 2026.
Moderately shorted, settled Sep 30, 2026, a few days of normal trading to cover. Down 6.3% since the previous count, down from 6.5% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How XENE is trading
Xenon Pharmaceuticals Inc. is −16% over the past year while the S&P 500 is +16%: 32 points behind the market. Through the fall, its own insiders bought $1.0M more stock than they sold.
1-year return · S&P 500 +16%
- vs 200-day average
- −32%
vs 200-day average · a clear downtrend
- RSI (14)
- 39
RSI (14) · neutral
- Below its 52-week high
- 50%
Below its 52-week high
Details›
- Last close2026-10-23
- $35.35
- 1 monthS&P 500 −0.94%
- −7.1%
- 1 yearS&P 500 +16%
- −16%
- 5 yearsS&P 500 +86%
- +12%
- vs 50-day average$47.93
- −26%
- 52-week high
- $70.97
- 52-week low
- $33.49
- Annualised volatility
- 57%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-22
- $1.0M
| Year | Return |
|---|---|
| 2026 (year to date) | −21% |
| 2025 | +14% |
| 2024 | −15% |
| 2023 | +17% |
| 2022 | +26% |
| 2021 | +103% |
| 2020 | +17% |
| 2019 | +108% |
| 2018 | +123% |
| 2017 | −63% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +3.8% |
| Feb | 10 | 7 of 10 | +7.2% |
| Mar | 10 | 3 of 10 | −3.1% |
| Apr | 10 | 5 of 10 | +4.1% |
| May | 10 | 3 of 10 | −4.5% |
| Jun | 10 | 6 of 10 | +7.7% |
| Jul | 11 | 5 of 11 | +3.1% |
| Aug | 11 | 8 of 11 | +7.7% |
| Sep | 11 | 2 of 11 | −7.9% |
| Oct | 11 | 5 of 11 | +5.3% |
| Nov | 10 | 7 of 10 | +4.1% |
| Dec | 10 | 7 of 10 | +7.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.